Andrew Cant
Overview
Explore the profile of Andrew Cant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walsh R, McNaughton P, Nademi Z, Laberko A, Balashov D, Al-Mousa H, et al.
J Clin Immunol
. 2025 Jan;
45(1):65.
PMID: 39762600
Receptor Interacting Serine/Threonine Kinase 1 (RIPK1) is widely expressed and integral to inflammatory and cell death responses. Autosomal recessive RIPK1-deficiency, due to biallelic loss of function mutations in RIPK1, is...
2.
Lum S, Sobh A, Carruthers K, Nademi Z, Watson H, McNaughton P, et al.
Bone Marrow Transplant
. 2022 Feb;
56(6):1483-1484.
PMID: 35145239
No abstract available.
3.
Lum S, Greener S, Perez-Heras I, Drozdov D, Payne R, Watson H, et al.
Blood Adv
. 2021 Dec;
6(4):1319-1328.
PMID: 34972212
Hematopoietic cell transplantation (HCT) has become standard-of-care for an increasing number of inborn errors of immunity (IEI). This report is the first to compare transplant outcomes according to T-cell-replete (ie,...
4.
Lankester A, Neven B, Mahlaoui N, von Asmuth E, Courteille V, Alligon M, et al.
J Allergy Clin Immunol
. 2021 Oct;
149(5):1744-1754.e8.
PMID: 34718043
Background: Hematopoietic stem cell transplantation (HSCT) represents a curative treatment for patients with severe combined immunodeficiency (SCID), a group of monogenic immune disorders with an otherwise fatal outcome. Objective: We...
5.
Lum S, Sobh A, Carruthers K, Nademi Z, Watson H, McNaughton P, et al.
Bone Marrow Transplant
. 2020 Nov;
56(5):1200-1204.
PMID: 33235352
No abstract available.
6.
Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency
Lum S, Selvarajah S, Deya-Martinez A, McNaughton P, Sobh A, Waugh S, et al.
J Allergy Clin Immunol
. 2020 May;
146(2):406-416.
PMID: 32442647
Background: Post hematopoietic cell transplantation (HCT) autoimmune cytopenia (AIC) is a potentially life-threatening complication, but studies focusing on large cohorts of patients transplanted for primary immunodeficiency are lacking. Objectives: This...
7.
Papa R, Cant A, Klein C, Little M, Wulffraat N, Gattorno M, et al.
Orphanet J Rare Dis
. 2020 Feb;
15(1):33.
PMID: 32000824
The Rare Immunodeficiency, AutoInflammatory and AutoImmune Disease (RITA) network is a European Research Network (ERN) that brings together the leading centres for rare immune disorders. On April 2018 an online...
8.
Lum S, Anderson C, McNaughton P, Engelhardt K, MacKenzie B, Watson H, et al.
Blood
. 2020 Jan;
135(12):954-973.
PMID: 31932845
MHC class II deficiency is a rare, but life-threatening, primary combined immunodeficiency. Hematopoietic cell transplantation (HCT) remains the only curative treatment for this condition, but transplant survival in the previously...
9.
Agache I, Annesi-Maesano I, Bonertz A, Branca F, Cant A, Fras Z, et al.
Allergy
. 2019 May;
74(11):2064-2076.
PMID: 31070805
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders...
10.
Watson C, Stockdale C, Berry I, Crinnion L, Carr I, Cant A, et al.
J Clin Immunol
. 2019 Apr;
39(3):270-273.
PMID: 30989467
No abstract available.